Koyfin Home > Directory > Health Care > Ampio Pharmaceuticals > Repurchase of Common Stock

Ampio Pharmaceuticals Repurchase of Common Stock Chart (AMPE)

Ampio Pharmaceuticals annual/quarterly Repurchase of Common Stock from 2014 to 2014.
  • Ampio Pharmaceuticals Repurchase of Common Stock for the quarter ending September 09, 2014 was $0m
  • Ampio Pharmaceuticals Repurchase of Common Stock for the last 12 months ending June 06, 2015 was $0m
Other Cash Flow Metrics:
  • Ampio Pharmaceuticals Cash Flow from Operations for the quarter ending September 09, 2018 was $-3m a 19.89% decrease of -1m year over year
  • Ampio Pharmaceuticals Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $-3m a 68.32% decrease of -2m year over year
  • Ampio Pharmaceuticals Total Revenue for the quarter ending December 12, 2015 was $0m a 95.43% increase of 0m year over year
View Chart On Koyfin

Quarterly AMPE Repurchase of Common Stock Data

09/2014$0m